A. Barzel, N. K. Paulk, Y. Shi, Y. Huang, K. Chu et al., , 2015.

, Promoterless gene targeting without nucleases ameliorates haemophilia B in mice, Nature, vol.517, pp.360-364

R. Gabriel, A. Lombardo, A. Arens, J. C. Miller, P. Genovese et al., An unbiased genome-wide analysis of zinc-finger nuclease specificity, Nat Biotechnol, vol.29, pp.816-823, 2011.

Y. Guan, Y. Ma, Q. Li, Z. Sun, L. Ma et al., CRISPR/ Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse, 2016.

, EMBO Mol Med, vol.8, pp.477-488

S. E. Khorsandi, P. Bachelier, J. C. Weber, M. Greget, D. Jaeck et al., Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human, Cancer Gene Ther, vol.15, pp.225-230, 2008.

H. Li, V. Haurigot, Y. Doyon, T. Li, S. Y. Wong et al., In vivo genome editing restores haemostasis in a mouse model of haemophilia, Nature, vol.475, pp.217-221, 2011.

C. S. Manno, G. F. Pierce, V. R. Arruda, B. Glader, M. Ragni et al., Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response, Nat Med, vol.12, pp.342-347, 2006.

, EMBO Molecular Medicine, vol.8, issue.5, 2016.

S. Ménoret, A. De-cian, L. Tesson, R. S. Usal, C. Boulé et al., Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins, Sci Rep, vol.5, p.14410, 2015.

A. C. Nathwani, U. M. Reiss, E. Tuddenham, C. Rosales, P. Chowdary et al., Longterm safety and efficacy of factor IX gene therapy in hemophilia B, N Engl J Med, vol.371, pp.1994-2004, 2014.

J. Renaud, C. Boix, M. Charpentier, A. De-cian, L. Perrouault et al., Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases, Cell Rep, vol.14, pp.2263-2272, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01371505

A. Toromanoff, Y. Chérel, M. Guilbaud, M. Penaudbuldoo, O. Snyder et al., Safety and efficacy of regional intravenous (RI) versus intramuscular (IM) delivery of rAAV1 and rAAV 1 and rAAV 8 to nonhuman primate skeletal muscle, Mol Ther, vol.16, pp.1291-1299, 2008.

H. Yin, W. Xue, S. Chen, R. L. Bogorad, E. Benedetti et al., Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype, Nat Biotechnol, vol.32, pp.551-553, 2014.

, License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited